An endocrinologist offers perspective on his reaction to EMPEROR-REDUCED topline results and what he hopes to see from the full results at ESC 2020.
Patrick Campbell
Advertisement
Patrick Campbell is the editorial director of HCPLive. Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter and/or multimedia specialist with the Pocono Record, Star News Group, and NJ Advance Media. He is the executive producer for multiple HCPLive podcasts, including Diabetes Dialogue, Don't Miss a Beat, Kidney Compass, Medical Ethics Unpacked, The Medical Sisterhood, and Skin of Color Savvy.
Follow him on Twitter @RealPatCampbell or reach him via email at [email protected].
Articles by Patrick Campbell
Analysis of CARDIA data indicates smoking was linked to greater volumes of adipose tissue and lower muscle quality, despite having a lower BMI.
An analysis of the STS/ACC Transcatheter Valve Therapy Registry reviews trends associated with use of the SAPIEN 3 transcatheter heart valve.
A nationwide assessment of data published between 2000-2020 related to outcomes following bariatric surgery is revealing more about its benefits on mortality and incidence of obesity-related disease.
A review of published articles is detailing the risk of new-onset and recurrent heart failure, respectively, in patients with diabetes mellitus.
Despite having lower BMI, the results of an analysis indicate smokers had greater adipose tissue volume than nonsmokers.
An analysis of data from 60 studies indicates being overweight or obese could have a negative impact on sperm and reproductive health in men.
A new University of Michigan-led study is detailing the effects of national cost-sharing caps on insulin for type 1 diabetics.
A study from BCVS 2020 is shedding light on the potential cardiovascular benefits of receiving a seasonal influenza vaccination in patients at high risk for the flu.
Deepak Bhatt, MD, MPH, discusses the latest REDUCE-IT data presented at ASPC 2020 in an exclusive interview with Practical Cardiology.
Jamie Hartmann-Boyce, MA, DPhil, discusses how medical researchers have adapted to the increased pace associated with the COVID-19 era.
S. Claiborne Johnston discusses the results of the phase 3 THALES trial examining use of ticagrelor dual antiplatelet therapy for reducing subsequent stroke in patients with AIS or TIA.
A study from Vanderbilt University Medical Center details the apparent risks associated with bleeding and venous thromboembolism following noncardiac surgery.
New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.
New research suggests risk of mortality associated with recombinant human growth hormone was linked to underlying diagnosis, not cumulative treatment or mean doses.
Guy Mintz, MD, discusses life as a practicing cardiologist during the ongoing COVID-19 pandemic.
A pooled analysis of 6 studies is shedding light on the relationship between early age at menarche and incidence of vasomotor menopausal symptoms.
A new study details the age-specific associations between high blood pressure and CVD risk among patients with diabetes.
New study finds 2 different time-restricted feeding approaches were effective for losing weight among obese patients.
A recent study is shedding light on the earliest signs of impaired cardiac function in diabetic patients.
New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.
New data from a randomized clinical trial conflicts current guidelines regarding levothyroxine treatment in heart attack patients.
A new study suggests supplemental cinnamon could help prevent prediabetes from converting to type 2 diabetes.
A prespecified analysis of ISAR-REACT 5 is shedding light on the effectiveness and safety of age- and weight-adjusted prasugrel versus ticagrelor following ACS.
New data from a study in Taiwan is detailing the complex interaction between physical activity and limiting exposure to high pollution levels.
New research details the impact increased systolic blood pressure can have on cardiovascular health of diabetics.
Results of the phase 3 THALES trial detail the effect of ticagrelor DAPT for reducing the risk of stroke and death in patients with acute ischemic stroke or transient ischemic attack.
A new study from investigators in the UK has uncovered potential signs of early heart failure in patients with type 2 diabetes.
New research suggests a diagnosis of prediabetes signaled increased risk of all-cause death or cardiovascular death in the next decade.
New data suggests heparin could mitigate SARS-CoV-2 ability to bind to human cells.
Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
2
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study
3
After Sickle Cell Gene Therapy, What Comes Next?
4
New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot
5